Request sample/catalog        CATALOG


 
 

 

 

Catalog no.

Description

Cases

Spots

Diameter

Price

Total

Cancer

Normal

A103(III)

Normal tissues, more than single spot(Duplicate)

54

108

0

108

1

N/A

A103(VI)

Normal tissues, more than single spot(Duplicate)

45

90

0

90

1

N/A

 

 

Catalog no.

Description

Cases

Spots

Diameter

Price

Total

Cancer

Normal

A201(V)

Various cancer tissues(Duplicate)

44

88

88

0

1

N/A

 


Catalog no.

Description

Cases

Spots

Diameter

Price

Total

Cancer

Normal

A202(VI)

Breast cancer tissues(Duplicate)

30

60

60

0

1

N/A

A203(I)

Colon cancer tissues(Duplicate)

50

104

100

4

1

N/A

A203(III)

Colon cancer tissues-liver metastasis

18

90

72

18

1

N/A

A203(IV)

Colon cancer tissues-liver metastasis

14

70

56

14

1.5

N/A

A203(VII)

Colon cancer tissues

45

98

90

8

1

N/A

A204

Liver cancer tissues-Hepatocellular carcinoma(Duplicate)

35

74

70

4

1

N/A

A204(II)

Liver cancer tissues-Hepatocellular carcinoma(Duplicate)

35

78

70

8

1

N/A

A205(II)

Liver cancer tissues-Cholangiocarcinoma(Duplicate)

46

96

92

4

1

N/A

A206

Lung cancer tissues(Duplicate)

40

84

80

4

1

N/A

A206(V)

Lung cancer tissues(Duplicate)

43

94

86

8

1

N/A

A207(II)

Pancreas cancer tissues(Duplicate)

30

64

60

4

1.5

N/A

A207(IV)

Pancreas cancer tissues(Duplicate)

33

74

66

8

1

N/A

A207(V)

Pancreas cancer tissues(Duplicate)

30

68

60

8

1

N/A

A209

Stomach cancer tissues(Duplicate)

50

104

100

4

1

N/A

A209(II)

Stomach cancer tissues(Duplicate)

40

88

80

8

1

N/A

A210

Thyroid cancer tissues(Duplicate)

33

70

66

4

1

N/A

A212

Uterus cancer tissues(Duplicate)

48

100

88

12

1

N/A

A213(II)

Ovary cancer tissues(Duplicate)

43

94

86

8

1

N/A

A214

Kidney(28 cases) and ureter(3 cases) cancer tissues

31

68

62

6

1

N/A

A215

Urinary bladder cancer tissues(Duplicate)

45

94

90

4

1

N/A

A215(II)

Urinary bladder cancer tissues(Duplicate)

40

84

80

4

1

N/A

A216

Skin cancer tissues(Duplicate)

50

104

100

4

1

N/A

A217

Hepatocellular carcinoma with B-viral history(Duplicate)

50

104

100

4

1

N/A

A218(I)

Esophagus cancer tissues(Duplicate)

40

84

80

4

1

N/A

A218(II)

Esophagus cancer tissues 

30

200

127

73

0.6

N/A

A218(III)

Esophagus cancer tissues(Duplicate)

40

88

80

8

1

N/A

A219

Head and neck cancer tissues(Duplicate)

45

94

90

4

1

N/A

A219(II)

Head and neck cancer tissues(Duplicate)

45

98

90

8

1

N/A

A220

Larynx cancer tissues(Duplicate)

45

94

90

4

1

N/A

A221(IV)

Brain cancer tissues: grade III ~ IV (Duplicate)

43

90

86

4

1

N/A

A221(V)

Brain cancer tissues (Duplicate)

35

70

70

0

1

N/A

A222

Prostate cancer tissues - Stage II (Duplicate)

45

94

90

4

1

N/A

A222(II)

Prostate cancer tissues -Stage II, III (Duplicate)

45

96

90

6

1

N/A

A222(III)

Prsotate cancer tissues -Stage II, III (Duplicate)

45

98

90

8

1

N/A

A223(II)

Prostate Cancer tissues - Sttage III (Duplicate)

45

98

90

8

1

N/A

A224

Lymphoma (Duplicate)

48

104

96

8

1

N/A

A225

Gastrointestinal stromal tumor tissues (Duplicate)

40

88

80

8

1

N/A

 

 

Catalog no.

Description

Cases

Spots

Diameter

Price

Total

Cancer

Normal

A301(I)

Various cancer tissues with non-corresponding normal tissues (Duplicate)

18

48

36

12

1

N/A

A301(V)

Various cancer tissues with corresponding normal tissues(Duplicate)

30

90

60

30

1

N/A

A302(III)

Prostate cancer tissues with corresponding normal tissues(Duplicate)

32

96

64

32

1

N/A

A302(IV)

Prostate cancer tissues with corresponding normal tissues(Duplicate)

32

96

64

32

1

N/A

A306

Lung cancer tissues w/ corresponding normal tissues(Duplicate)

32

96

64

32

1

N/A

A307

Pancreas cancer tissues w/ corresponding normal tissues(Duplicate)

30

90

60

30

1

N/A

A312

Breast cancer tissues w/ corresponding normal tissues(Duplicate)

20

60

40

20

1

N/A

 

Catalog no.

Description

Cases

Spots

Diameter

Price

Total

Cancer

Normal

A401

Thyroid disease tissues(Duplicate)

30

64

60

4

1

N/A

 

Catalog no.

Description

Cases

Spots

Diameter

Price

Total

Cancer

Normal

A700(III)

Test slide-various normal tissues

12

12

0

12

1

N/A

A701(VI)

Test slide - various cancer tissues with corresponding normal tissues

12

24

12

12

1

N/A

A712(XII)

Test slide - Breast cancer tissues with corresponding normal tissues

12

24

12

12

1

N/A

A712(13)

Test slide - Breast cancer tissues with corresponding normal tissues

12

24

12

12

1

N/A

A713(II)

Test slide - Colon cancer tissues_liver metastasis with corresponding normal tissues

4

20

16

4

1.5

N/A

A713(IV)

Test slide - colon cancer tissues with corresponding normal tissues 

12

24

12

12

1

N/A

A713(V)

Test slide - colon cancer tissues with corresponding normal tissues 

12

24

12

12

1

N/A

A713(VI)

Test slide - colon cancer tissues with corresponding normal tissues 

12

24

12

12

1

N/A

A714

Test slide-liver cancer tissues w/ corresponding normal tissues

6

12

6

6

1

N/A

A716(IV)

Test slide-Lung cancer tissues w/ corresponding normal tissues

12

24

12

12

1

N/A

A717(II)

Test slide- pancreas cancer tissues with corresponding normal tissues

6

12

6

6

1

N/A

A717(III)

Test slide- pancreas cancer tissues with corresponding normal tissues

12

24

12

12

1

N/A

A718(V)

Test slide - Prostate cancer tissues with corresponding normal tissues

6

12

6

6

1

N/A

A718(VII)

Test slide - Prostate cancer tissues with corresponding normal tissues

6

12

6

6

1

N/A

A718(VIII)

Test slide - Prostate cancer tissues with corresponding normal tissues

6

12

6

6

1

N/A

A729

Test slide-Head and neck cancer tissues
with corresponding normal tissues

6

12

6

6

1

N/A

 

Tissue Types

Catalog No.

Description

Cases

Spots

Slides/
Package

Price (USD)

Frozen


Section

A904

Breast: Infiltrating ductal carcinoma

1

1

5

N/A

A905

Colon: adenocarcinoma

1

1

5

N/A

A906

Lung: squamous cell carcinoma

1

1

5

N/A

A908

Lung: adenocarcinoma

1

1

5

N/A

A912

Kidney: renal cell carcinoma

1

1

5

N/A

A913

Liver cancer

1

1

5

N/A

A914

Stomach: adenocarcinoma

1

1

5

N/A

A915

Stomach: signet ring cell carcinoma

1

1

5

N/A

A916

Rectum: adenocarcinoma

1

1

5

N/A

A917

Ovary: MMMT(Malignatn mixed mullerian tumor)

1

1

5

N/A

A918

Prostate: adenocarcinoma

1

1

5

N/A

A919

GIST

1

1

5

N/A

A920

Thyroid: papillary carcinoma

1

1

5

N/A

A922

Kidney: agniomyolipoma

1

1

5

N/A

A925

Urinary bladder: adenocarcinoma

1

1

5

N/A

A929

Esophagus: basaloid squamous cell carcinoma

1

1

5

N/A

A930

Lymphoma

1

1

5

N/A

A933

Testis: seminoma

1

1

5

N/A

A934

Thymus: thymoma

1

1

5

N/A

A935

Rectum: Tubulovillous adenomas

1

1

5

N/A

Frozen Tissue Arrays

A1203(I)

Colon Frozen cancer tissue arrays

6

18

5

N/A

A1205(I)

Lung Frozen cancer tissue arrays

6

18

5

N/A

A1301(I)

Various Frozen cancer tissue arrays

6

12

5

N/A

Note: Additional shipping cost will be charged. The cost will depend on the weight of dry ice.


Protocol  


Customer comments
         
         "I would like to try test slides A712 and A718. I already placed the order yesterday for 8 different arrays,
          some were in duplicates. I liked my previous results with your lung and multi-tissue Ca arrays. The quality
          was very good. I can tell this based on my extensive experience with other companies. You do an
         excellent job." - Svetlana Pack, Ph.D. LIP/NIAID/NIH

         "In comparison to the arrays we have produced ourselves or received from collaborators, the ones we got
         from ISU ABXIS were of superior quality. Before a lot of tissue cores detached during the processing or
         the morphology was compromised. Not so with the one we received from you. It had outstanding tissue
         morphology and the information on each sample found on the accompanying CD was exceeding my
         expectations. In addition, it is helpful for analysis  to have more than one core of each sample. After
        sectioning a few slides from our in-house arrays most tissues were not available due to different core
        thickness, so yours provides much better consistency and we have already ordered more of the esophageal
        array we tested. Thank you for providing such outstanding service." - Claudia Andl, Ph.D. from University of
         Pennsylvania.

     
        "I wanted to let you know that we have used the various tissue arrays and were very much impressed
         by the quality of tissue preparation and preservation. We are having an outside pathologist look also
         at the staining in more detail to evaluate tissue quality but it looks really great. We will proceed with
         some candidate antibody and we are definitely interested in further your services and business as we
         are developing new target and antibody in the near future. Thank you very much."- Pharmaceutical company

         "I found the TMAs to be well preserved, good morphology, good variety of tumor types, adequate tissues
          in each sample, and they stained well for immunohistochemistry. I think such arrays would work great
          for first pass screening." - Pharmaceutical company

       References

No.

Published

AccuMax Array

Journal

Paper Title

Organization

1

2004

Colon_Custom TMA

Oncogene (I)

Different gene expression profiles between microsatellite instability-high and microsatellite stable colorectal carcinomas

Yonsei University

2

2004

A221_Brain

Cancer Cell

Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, angiopoietin-1, and matrix metalloproteinases

Harvard Medical School

3

2004

A301_Various Ca.

Oncogene (II)

Role of the BLT2, a leukotriene B4 receptor, in Ras transformation

Korea University

4

2005

A301_Various Ca.

Cell Death and Differentiation

Cyclin G1 overcomes radiation-induced G2 arrest and increases cell death through transcriptional activiation of cyclin B1

Korea Institute of Radiological and Medical Sciences

5

2005

A207_Pancreas

Cancer Research

Overexpressed P-Cadherin/CDH3 Promotes Motility of Pancreatic Cancer Cells by Interacting with p120ctn and Activating Rho-Family GTPases

Laboratory of Molecular Medicine, Human Genome Center, The University of Tokyo

6

2005

A202_Breast/
A207_Pancreas

Cancer Cell

CUTL1 is a target of TGF¥â signaling that enhances cancer cell motility and invasiveness

Cancer Research UK 

7

2005

A401_Thyroid

British Journal of Cancer

Decreased expression of haemoglobin beta(HBB) gene in anaplastic thyroid cancer recovery of its expression inhibits cell growth

Nippon Medical SchoolKanagawa Prefectural Cancer Center

8

2005

Custom TMA

Invasive Ductal Carcinoma of Breast

Immuohistochemical and Clinicopathologic Characteristics of Invasive Ductal Carcinoma of Breast with Micropapillary Carcinoma Component

Univ. of Ulsan College of Medicine, Ajou University

9

2005

Custom TMA

Oncogene

Correlation of KIT and platelet-derived growth factor receptor ¥á mutations with gene activation and expression profiles in gastrointestina stromal tumors

Yonsei University

10

2006

A202(III)_Breast

Molecular Cancer Therapeutics

C35(C17orf37) is a novel tumor biomaker abundantly expressed in breast cancer

Vaccinex, INC.

11

2006

A302_Prostate

Cell

Macrophage/Cancer Cell interactions Mediate Hormone Resistance by a Nuclear Receptor Derepression Pathway

Univ. of California

12

2006

A712(II)_Breast

Journal of Biological Chemistry

Lysyl Oxidase Interacts w/ Hormone Placental Lactogen and Synergistically Promotes Breast Epithelial Cell Proliferation and Migration

Cardiovascular Research Center, Univ. of Hawaii

13

2006

A215_Urinary

Clinical Cancer Research

Molecular Profiling of ADAM12 in human Bladder Cancer

Institute of Molecular Pathology, Univ. of Copenhagen

14

2006

Prostate

Clinical Cancer Research

Expression of Novel Molecules, MICAL2-PV (MICAL2 Prostate Cancer Variants), Increas with High Gleason Score and Prostate Cancer Progression

Human Genome Center, Tokyo University

15

2006

A206_Lung

Respiratory Research

WFDC2(HE4): A potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung

University of Sheffield

16

2006

A218_Esophagus Ca.

Cancer Research

Coordinated Functions of E-Cadherin and Transforming Growth Factor ¥â Receptor II in vitro and In Vivo

Abramson Cancer Center

17

2006

A207_Pancreas

Japanese Cancer Association

EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth

Human Genome Center, Tokyo University

18

2007

A218_Esophagus Ca.

The American Journal of Pathology

Dysregulation of Caludin-7 Leads to Loss of E-Cadherin Expression and the Increased Invasion of Esophageal Squamous Cell Carcinoma Cells

The Wistar Institute, Univ. of Pennsylvania

19

2007

¡¡

Molecular Cancer Therapeutics

The glycotope-specific RAV12 monoclonal antibody induces oncosis in vitro and has antitumor activity against gastrointestinal adenocrcinoma tumor xenografts in vivo

Raven Biotechnologies Inc.

20

2007

A207_Pancreas

Cancer Research

Intersex-like (IXL) is a Cell Survival Regulator n Pancreatic Cancer with 19q13 Amplification

Laboratory of Cancer Genetics

21

2007

A207(III)_Pancreas

Carcinogenesis Advance Access

WNT5A - target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer

University of Ulm

22

2007

A202_Breast

Cell Biology

CXCR7(RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature

ChemoCentryx, Inc

23

2007

A213_Ovary

Journal of Histochemistry and Cytochemistry

Combined Staining of TAG-72, MUC1, and CA125 Improves Labeling Sensitivity in Ovarian Cancer: Antigens for Multi-targeted Antibody-guided Therapy

Cancer Biology Research Institute

24

2007

A207_Pancreas

Modern Pathology

Upregulation and redistribution of integrin 64 expression occurs at an early stage in pancreatic adenocarcinoma progression

Uniiversity of Taxas

25

2007

Breast, Colon, Lung, Pancreas

BMC Cancer

Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers

Garden State Cancer Center

26

2007

Prostate

Molecular Endocrinology

Proline-, Glutamic Acid-, and Leucine-Rich Protein 1/Modulator of Nongenomic Activity of Estrogen Receptor Enhances Androgen Receptor Functions through LIM-only Coactivator, Four-and-a-half LIM-only Protein 2

University of Texan MD Anderson Cancer Center

27

2007

A216_Skin

Journal of Molecular Medicine

Involvement of deterioration in S100C/A11- mediated pathway in resistance of human squamous cancer cell lines to TGF¥â-induced growth suppression

Okayama University

28

2007

A207(III)_ Pancreas

 

Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependentand androgen-independent prostate cancer cells

University of Nebraska

29

2008

Skin

Asian Pacific Journal of Cancer

Methylthioadenosine Phosphorylase Expression in Cutaneous Squamous Cell Carcinoma

University of Brunei Darussalam

30

2008

A103_Normal

PLoS

The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells in Vivo: A Novel 'Alarmin'?

University of Toulouse